Modulation of the host's immune response by schistosome larvae

Parasite Immunology

Volumn 27, Issue 10-11, 2005, Pages 385-393

  Jenkins, S J ^a,b   Hewitson, J P ^a   Jenkins, G R ^a   Mountford, Adrian P ^a  

^a UNIVERSITY OF YORK   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cytokine; Helminth; Immunomodulation; Schistosomes

Indexed keywords

GLYCAN DERIVATIVE; HISTAMINE; ICOSANOID; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LECTIN; PROSTAGLANDIN D2; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; APOPTOSIS; CELL ACTIVATION; CERCARIA; CYTOKINE PRODUCTION; DOWN REGULATION; EGG; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOMODULATION; IMMUNOSTIMULATION; MAST CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SKIN; SURVIVAL; T LYMPHOCYTE;

ANIMALS; ANTIGEN-PRESENTING CELLS; ANTIGENS, HELMINTH; APOPTOSIS; HELMINTH PROTEINS; HUMANS; LARVA; LYMPHOCYTES; MAST CELLS; SCHISTOSOMA; SCHISTOSOMIASIS;

SCHISTOSOMA; VERMES;

EID: 26244439286     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2005.00789.x     Document Type: Review

References (81)

1. Muller R. Worms and Human Disease, 2nd edn. Wallingford, Oxon, UK: CABI Publishing; 2002.
2. King CL. Chapter 6. Initiation and regulation of disease in schistosomiasis. In Mahmoud AAF (ed.): Schistosomiasis. London: Imperial College Press; 2001, pp. 213-264.
3. Stavitsky AB. Regulation of granulomatous inflammation in experimental models of schistosomiasis. Infect Immun 2004; 72: 1-12.
4. Weinstock JV & Boros DL. Heterogeneity of the granulomatous response in the liver, colon, ileum, and ileal Peyer's patches to schistosome eggs in murine schistosomiasis mansoni. J Immunol 1981; 127: 1906-1909.
5. Stadecker MJ, Asahi H, Finger E, Hernandez HJ, Rutitzky LI & Sun J. The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol Rev 2004; 201: 168-179.
6. Wynn TA, Thompson RW, Cheever AW & Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev 2004; 201: 156-167.
7. Pearce EJ & MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol 2002; 2: 499-511.
8. Mountford AP & Trottein F. Schistosomes in the skin: a balance between immune priming and regulation. Trends Parasitol 2004; 20: 221-226.
9. McKerrow JH & Salter J. Invasion of skin by Schistosoma cercariae. Trends Parasitol 2002; 18: 193-195.
10. Curwen RS & Wilson RA. Invasion of skin by schistosome cercariae: some neglected facts. Trends Parasitol 2003; 19: 63-65.
11. Whitfield PJ, Bartlett A, Brown MB & Marriott C. Invasion by schistosome cercariae: studies with human skin explants. Trends Parasitol 2003; 19: 339-340.
12. Mountford AP, Coulson PS & Wilson RA. Antigen localization and the induction of resistance in mice vaccinated with irradiated cercariae of Schistosoma mansoni. Parasitology 1988; 97 (Pt 1): 11-25.
13. Wilson RA, Coulson PS, Sturrock RF & Reid GD. Schistosome migration in primates: a study in the olive baboon (Papio anubis). Trans R Soc Trop Med Hyg 1990; 84: 80-83.
14. He YX, Chen L & Ramaswamy K. Schistosoma mansoni, S. haematobium, and S. japonicum: early events associated with penetration and migration of schistosomula through human skin. Exp Parasitol 2002; 102: 99-108.
15. Wang L, Li YL, Fishelson Z, Kusel JR & Ruppel A. Schistosoma japonicum migration through mouse skin compared histologically and immunologically with S. mansoni. Parasitol Res 2005; 95: 218-223.
16. Haas W & Pietsch U. Migration of Trichobilharzia ocellata schistosomula in the duck and the abnormal murine host. Parasitol Res 1991; 77: 642-644.
17. Kourilova P, Hogg KG, Kolarova L & Mountford AP. Cercarial dermatitis caused by bird schistosomes comprises both immediate and late phase cutaneous hypersensitivity reactions. J Immunol 2004; 172: 3766-3774.
18. Kourilova P, Syrucek M & Kolarova L. The severity of mouse pathologies caused by the bird schistosome Trichobilharzia regenti in relation to host immune status. Parasitol Res 2004; 93: 8-16.
19. Ramaswamy K, Kumar P & He YX. A role for parasite-induced PGE2 in IL-10-mediated host immunoregulation by skin stage schistosomula of Schistosoma mansoni. J Immunol 2000; 165: 4567-4574.
20. Angeli V, Faveeuw C, Roye O et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med 2001; 193: 1135-1147.
21. + cells is a major feature of the innate immune response in mice that develop Th1-mediated protective immunity to Schistosoma mansoni. Infect Immun 2003; 71: 3563-3571.
22. Hogg KG, Kumkate S & Mountford AP. IL-10 regulates early IL-12-mediated immune responses induced by the radiation-attenuated schistosome vaccine. Int Immunol 2003; 15: 1451-1459.
23. Kumar P & Ramaswamy K. Vaccination with irradiated cercariae of Schistosoma mansoni preferentially induce the accumulation of interferon-gamma producing T cells in the skin and skin-draining lymph nodes of mice. Parasitol Int 1999; 48: 109-119.
24. Moore KW, de Waal Malefyt R, Coffman RL & O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19: 683-765.
25. Hoffmann KF, James SL, Cheever AW & Wynn TA. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 1999; 163: 927-938.
26. + regulatory T cells. Trends Immunol 2004; 25: 374-380.
27. Mills KH & McGuirk P. Antigen-specific regulatory T cells - their induction and role in infection. Semin Immunol 2004; 16: 107-117.
28. Mendez S, Reckling SK, Piccirillo CA, Sacks D & Belkaid Y. Role for CD4(+) CD25(+) regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J Exp Med 2004; 200: 201-210.
29. Gorelik L & Flavell RA. Transforming growth factor-beta in T-cell biology. Nat Rev Immunol 2002; 2: 46-53.
30. Fusco AC, Salafsky B & Delbrook K. Schistosoma mansoni: production of cercarial eicosanoids as correlates of penetration and transformation. J Parasitol 1986; 72: 397-404.
31. Salafsky B & Fusco AC. Schistosoma mansoni: a comparison of secreted vs nonsecreted eicosanoids in developing schistosomulae and adults. Exp Parasitol, 1987; 64: 361-367.
32. 2 enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J Immunol 2002; 168: 2255-2263.
33. Ramaswamy K, Salafsky B, Potluri S, He YX, Li JW & Shibuya T. Secretion of an anti-inflammatory, immunomodulatory factor by Schistosomulae of Schistosoma mansoni. J Inflamm 1995; 46: 13-22.
34. Gately MK, Carvajal DM, Connaughton SE et al. Interleukin-12 antagonist activity of mouse interleukin-12 p40 homodimer in vitro and in vivo. Ann N Y Acad Sci 1996; 795: 1-12.
35. Stirewalt MA. Schistosoma mansoni: cercaria to schistosomule. Adv Parasitol 1974; 12: 115-182.
36. Cousin CE, Stirewalt MA & Dorsey CH. Schistosoma mansoni: ultrastructure of early transformation of skin- and shear-pressure-derived schistosomules. Exp Parasitol 1981; 51: 341-365.
37. Samuelson JC & Caulfield JP. Loss of covalently labeled glycoproteins and glycolipids from the surface of newly transformed schistosomula of Schistosoma mansoni. J Cell Biol 1982; 94: 363-369.
38. Salter JP, Choe Y, Albrecht H et al. Cercarial elastase is encoded by a functionally conserved gene family across multiple species of schistosomes. J Biol Chem 2002; 277: 24618-24624.
39. Lightowlers MW & Rickard MD. Excretory-secretory products of helminth parasites: effects on host immune responses. Parasitology 1988; 96 Suppl: S123-S166.
40. Vieira LQ, Gazzinelli G, Kusel JR, De Souza CP & Colley DG. Inhibition of human peripheral blood mononuclear cell proliferative responses by released materials from Schistosoma mansoni cercariae. Parasite Immunol 1986; 8: 333-343.
41. Mountford AP, Harrop R & Wilson RA. Antigens derived from lung-stage larvae of Schistosoma mansoni are efficient stimulators of proliferation and gamma interferon secretion by lymphocytes from mice vaccinated with attenuated larvae. Infect Immun 1995; 63: 1980-1986.
42. Teixeira MM, Doenhoff MJ, McNeice C, Williams TJ & Hellewell PG. Mechanisms of the inflammatory response induced by extracts of Schistosoma mansoni larvae in guinea pig skin. J Immunol 1993; 151: 5525-5534.
43. Fallon PG, Teixeira MM, Neice CM, Williams TJ, Hellewell PG & Doenhoff MJ. Enhancement of Schistosoma mansoni infectivity by intradermal injections of larval extracts: a putative role for larval proteases. J Infect Dis 1996; 173: 1460-1466.
44. Harn DA, Cianci CM & Caulfield JP. Schistosoma mansoni: immunization with cercarial glycocalyx preparation increases the adult worm burden. Exp Parasitol 1989; 68: 108-110.
45. Machado DC, Horton D, Harrop R, Peachell PT & Helm BA. Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol 1996; 26: 2972-2980.
46. Catto BA, Lewis FA & Ottesen EA. Cercaria-induced histamine release: a factor in the pathogenesis of schistosome dermatitis? Am J Trop Med Hyg 1980; 29: 886-889.
47. Rao KV, Chen L, Gnanasekar M & Ramaswamy K. Cloning and characterization of a calcium-binding, histamine-releasing protein from Schistosoma mansoni. J Biol Chem 2002; 277: 31207-31213.
48. Mazzoni A, Young HA, Spitzer JH, Visintin A & Segal DM. Histamine regulates cytokine production in maturing dendritic cells, resulting in altered T cell polarization. J Clin Invest 2001; 108: 1865-1873.
49. Caron G, Delneste Y, Roelandts E et al. Histamine polarizes human dendritic cells into Th2 cell-promoting effector dendritic cells. J Immunol 2001; 167: 3682-3686.
50. van der Pouw Kraan TC, Snijders A, Boeije LC et al. Histamine inhibits the production of interleukin-12 through interaction with H2 receptors. J Clin Invest 1998; 102: 1866-1873.
51. Jutel M, Watanabe T, Akdis M, Blaser K & Akdis CA. Immune regulation by histamine. Curr Opin Immunol 2002; 14: 735-740.
52. James ER & Green DR. Manipulation of apoptosis in the host-parasite interaction. Trends Parasitol 2004; 20: 280-287.
53. Chen L, Rao KV, He YX & Ramaswamy K. Skin-stage schistosomula of Schistosoma mansoni produce an apoptosis-inducing factor that can cause apoptosis of T cells. J Biol Chem 2002; 277: 34329-34335.
54. Dunne DW & Mountford AP. Chapter 5. Resistance to infection in humans and animal models. In Mahmoud AAF. (ed.): Schistosomiasis. London: Imperial College Press; 2001, pp. 133-212.
55. Jenkins SJ & Mountford AP. Dendritic cells activated with products released by schistosome larvae drive Th2-type immune responses, which can be inhibited by manipulation of CD40 costimulation. Infect Immun 2005; 73: 395-402.
56. Pearce EJ, Kane CM, Sun J, Taylor JJ, McKee AS & Cervi L. Th2 response polarization during infection with the helminth parasite Schistosoma mansoni. Immunol Rev 2004; 201: 117-126.
57. MacDonald AS, Straw AD, Bauman B & Pearce EJ. CD8-dendritic cell activation status plays an integral role in influencing Th2 response development. J Immunol 2001; 167: 1982-1988.
58. Cervi L, MacDonald AS, Kane C, Dzierszinski F & Pearce EJ. Cutting edge: dendritic cells copulsed with microbial and helminth antigens undergo modified maturation, segregate the antigens to distinct intracellular compartments, and concurrently induce microbe-specific Th1 and helminth-specific Th2 responses. J Immunol 2004; 172: 2016-2020.
59. van der Kleij D, Latz E, Brouwers JF et al. A novel host-parasite lipid cross-talk. Schistosomal lyso-phosphatidylserine activates Toll-like receptor 2 and affects immune polarization. J Biol Chem 2002; 277: 48122-48129.
60. Underhill DM & Gantner B. Integration of Toll-like receptor and phagocytic signaling for tailored immunity. Microbes Infect 2004; 6: 1368-1373.
61. Thomas PG, Carter MR, Atochina O et al. Maturation of dendritic cell 2 phenotype by a helminth glycan uses a Toll-like receptor 4-dependent mechanism. J Immunol 2003; 171: 5837-5841.
62. Thomas PG, Harn DA Jr. Immune biasing by helminth glycans. Cell Microbiol 2004; 6: 13-22.
63. Velupillai P, Secor WE, Horauf AM, Harn DA. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997; 158: 338-344.
64. Velupillai P, dos Reis EA, dos Reis MG, Harn DA. Lewis(x)-containing oligosaccharide attenuates schistosome egg antigen-induced immune depression in human schistosomiasis. Hum Immunol 2000; 61: 225-232.
65. van der Kleij D, Van Remoortere A, Schuitemaker JH et al. Triggering of innate immune responses by schistosome egg glycolipids and their carbohydrate epitope GalNAc beta 1-4(Fuc alpha 1-2Fuc alpha 1-3)GlcNAc. J Infect Dis 2002; 185: 531-539.
66. Nyame AK, Kawar ZS & Cummings RD. Antigenic glycans in parasitic infections: implications for vaccines and diagnostics. Arch Biochem Biophys 2004; 426: 182-200.
67. Faveeuw C, Mallevaey T, Paschinger K et al. Schistosome N-glycans containing core alpha 3-fucose and core beta 2-xylose epitopes are strong inducers of Th2 responses in mice. Eur J Immunol 2003; 33: 1271-1281.
68. Nyame AK, Lewis FA, Doughty BL, Correa-Oliveira R & Cummings RD. Immunity to schistosomiasis: glycans are potential antigenic targets for immune intervention. Exp Parasitol 2003; 104: 1-13.
69. Robijn ML, Wuhrer M, Kornelis D, Deelder AM, Geyer R & Hokke CH. Mapping fucosylated epitopes on glycoproteins and glycolipids of Schistosoma mansoni cercariae, adult worms and eggs. Parasitology 2005; 130: 67-77.
70. Van Remoortere A, Hokke CH, van Dam GJ, van Die I, Deelder AM & van den Eijnden DH. Various stages of Schistosoma express Lewis(x), LacdiNAc, GalNAcbeta1-4(Fucalpha1-3)GlcNAc and GalNAcbeta1-4(Fucalpha1-2Fucalpha1-3) GlcNAc carbohydrate epitopes: detection with monoclonal antibodies that are characterized by enzymatically synthesized neoglycoproteins. Glycobiology 2000; 10: 601-609.
71. Huang HH, Tsai PL & Khoo KH. Selective expression of different fucosylated epitopes on two distinct sets of Schistosoma mansoni cercarial O-glycans: identification of a novel core type and Lewis X structure. Glycobiology 2001; 11: 395-406.
72. Wuhrer M, Dennis RD, Doenhoff MJ, Lochnit G & Geyer R. Schistosoma mansoni cercarial glycolipids are dominated by Lewis X and pseudo-Lewis Y structures. Glycobiology 2000; 10: 89-101.
73. van Kooyk Y, Engering A, Lekkerkerker AN, Ludwig IS & Geijtenbeek TB. Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curr Opin Immunol 2004; 16: 488-493.
74. van Kooyk Y & Geijtenbeek TB. DC-SIGN: escape mechanism for pathogens. Nat Rev Immunol 2003; 3: 697-709.
75. Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB & van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003; 170: 1635-1639.
76. van Die I, van Vliet SJ, Nyame AK et al. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003; 13: 471-478.
77. Chieppa M, Bianchi G, Doni A et al. Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J Immunol 2003; 171: 4552-4560.
78. Martinez-Pomares L, Kosco-Vilbois M, Darley E et al. Fc chimeric protein containing the cysteine-rich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers. J Exp Med 1996; 184: 1927-1937.
79. Herve M, Angeli V, Pinzar E et al. Pivotal roles of the parasite PGD2 synthase and of the host D prostanoid receptor 1 in schistosome immune evasion. Eur J Immunol 2003; 33: 2764-2772.
80. MacDonald AS, Straw AD, Dalton NM & Pearce EJ. Th2 response induction by dendritic cells: a role for CD40. J Immunol 2002; 168: 537-540.
81. Jenkins SJ, Hewitson JP, Ferret-Bernard S & Mountford AP. Schistosome larvae stimulate macrophage cytokine production through TLR4-dependent and independent pathways. Int Immunol 2005, in press.